What can we learn from chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies

Journal of Clinical Psychopharmacology

Volumn 31, Issue 2, 2011, Pages 194-200

  Koesters, Markus ^a   Zhang, Ying ^a   Chun, Yong ^b   Weinmann, Stefan ^c   Becker, Thomas ^a   Jin, Wei Dong ^b  

^a UNIVERSITY OF ULM   (Germany)

^b Tongde Hospital   (China)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

China; Chinese studies; depression; meta analysis; venlafaxine

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; CHINESE; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; HAMILTON SCALE; HUMAN; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REMISSION; SYSTEMATIC REVIEW; TREATMENT EMERGENT SYMPTOM SCALES; UNSPECIFIED SIDE EFFECT;

ASIAN CONTINENTAL ANCESTRY GROUP; CYCLOHEXANOLS; DEPRESSIVE DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79952438806     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31820f932a     Document Type: Article

References (55)

1. Zhou P, Leydesdorff L. The emergence of China as a leading nation in science. Res Policy. 2006;35:83-104. (Pubitemid 43186009)
2. Wilsdon J, Keeley J. China: The Next Science Superpoweri London, UK: Demos; 2007.
3. Egger M, Zellweger-Zahner T, Schneider M, et al. Language bias in randomised controlled trials published in English and German. Lancet. 1997;350:326-329. (Pubitemid 27351115)
4. Jüni P, Holenstein F, Sterne J, et al. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol. 2002;31:115-123. (Pubitemid 34284912)
5. Moher D, Fortin P, Jadad AR, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet. 1996;347:363-366. (Pubitemid 26046104)
6. Vickers A, Goyal N, Harland R, et al. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials. 1998;19:159-166. (Pubitemid 28191970)
7. Correll CU, Rummel-Kluge C, Corves C, et al. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull. 2009;35:443-457.
8. Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on meta-analysis. J Clin Epidemiol. 1995;48:167-171.
9. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
10. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 2009. Available at: http://www.cochrane-handbook. org. Accessed March 10, 2010.
11. Weinmann S, Becker T, Koesters M. Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis. Psychopharmacology. 2008;196:511-520. (Pubitemid 351623005)
12. Cipriani A, Furukawa P, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet. 2009;373:746-758.
13. Nemeroff CB, Entsuah R, Benattia I, et al. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biol Psychiatry. 2008;63:424-434.
14. Bauer M, Tharmanathan P, Volz H-P, et al. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2009;259:172-185.
15. Xia J, Wright J, Adams CE. Five large Chinese biomedical bibliographic databases: accessibility and coverage. Health Info Libr J. 2008;25:55-61. (Pubitemid 351599109)
16. Schueler YB, Koesters M, Wieseler B, et al. A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. Acta Psychiatr Scand. 2010 [Epub ahead of print]. DOI: 10.1111/j.1600-0447.2010. 01599.x.
17. National Insitute for Health and Clinical Excellence. DepressionVThe Treatment and Management of Depression in Adults (Updated Edition). 2009. Available at: http://www.nice.org.uk/nicemedia/live/12329/ 45896/45896.pdf. Accessed September 17, 2010.
18. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191-1194. (Pubitemid 32378696)
19. Comprehensive Meta-analysis [computer program]. Version 2. Englewood, NJ: Biostat; 2005.
20. R: A Language and Environment for Statistical Computing [computer program]. Version 2.9.1. Vienna, Austria: R Foundation for Statistical Computing; 2009.
21. Chang FW. A comparative study of venlafaxine and clomipramine in the treatment of depression. Clin Med. 2003;23:45-46.
22. Chen HH. Controlled study of venlafaxine and amitriptyline in the treatment of depression. Med J Chin Civil Adm. 2002;14:334-335.
23. Du HY. A control study of venlafaxine and amitriptyline in senile depression. J Clin Psychosom Dis. 2005;11:127-128.
24. Du XH, Du XX, Teng GH, et al. A comparative study of venlafaxine and imipramine in the treatment of depression. Shandong Arch Psychiatry. 2004;17:11-13.
25. Feng NX, Hong ZQ, Jiang H, et al. A double-blind controlled study of venlafaxine and imipramine in patients with depressive disorder. Sichuan Mental Health. 2001;14:107-108.
26. Li YF, Feng YG, Yang FS, et al. A comparative study of venlafaxine and maprotiline in the treatment of senile depression. Chin J Health Psychol. 2005;13:102-103.
27. Liu GJ, Wang JQ, Lu YR. A comparative study of venlafaxine and clomipramine in the treatment of depression. Shandong Arch Psychiatry. 2006;19:135-136.
28. Lu L, Huang MS, Sun XL, et al. A multicenter, double-blind, comparative study of venlafaxine and amitriptyline in the treatment of depression. Chin J Nerv Mental Dis. 1998;24:35-37.
29. Lu L, Huang MS, Wang ZX, et al. A study on the efficacy of venlafaxine in treatment of senile depression in comparison with amitriptyline. Chin J N Drugs. 1999;8:188-190.
30. Lu XJ, Ma XJ. 170 cases of venlafaxine in the treatment of depression. Chin J Clin Med Res. 2008;17:74.
31. Ou HX, Zhang XB, Qiao HF, et al. A controlled study in the treatment of depression with venlafaxine extended release. J Clin Psychol Med. 2001;11:105-106.
32. Qin SP. The efficacy and tolerability of venlafaxine and fluoxetine in the treatment of patients with first-episode depression. Med J Chin Peoples Health. 2006;18:519-521.
33. Qu CS, Wang PY. A comparative study of venlafaxine and amitriptyline in the treatment of depression. Med J Chin Peoples Health. 2004;16:225-227.
34. Song RG, Ren J. A comparative study of venlafaxine and amitriptyline in the treatment of depression. J Clin Psychol Med. 2001;11:176-177.
35. Song SY, Yuan F. A comparative study of depression treatment effects with venlafaxine and amitriptyline. Health Psychol J. 2003;11:112-113.
36. Sun CY, Wang GH, Zhou T, et al. A comparative clinical study for venlafaxine versus fluoxetine in the treatment of depression. Chin J N Drugs. 2005;14:617-619.
37. Sun GB. Comparisons of the efficacy and tolerability of escitalopram and extended-release venlafaxine in the treatment of depression. Chin Pharm. 2010;19:56-57.
38. Wang H, Zhao CS, Ma L, et al. A double-blind comparison of venlafaxine (made in China) and doxepinnum for major depression and melancholia. Med J Chin Peoples Health. 2003;15: 517-518.
39. Wei SZ. The controlled study on venlafaxine and fluoxetine in depression. Nerv Dis Mental Health. 2006;6:352-353.
40. Xu FL, Wen CG, Cao KS, et al. Comparision of venlafaxine vs maprotiline in the treatment of 83 patients with depression. Chin J N Drugs. 2002;11:727-728.
41. Zhang JD, Feng RM, Ma C. A doube-blind comparison of venlafaxine and amitriptyline in the treatment of depression. Guangzhou Med J. 2000;31:8-9.
42. Zhang J, Fan FL, Liu SQ. Comparison of venlafaxine with imipramine on post-stroke depression. Health Psychol J. 2004;12:132-134.
43. Zhang ZQ, Yang XR, Wang XD. A clinical control study of venlafaxine and fluoxetine in the treatment of depression patients. Chin J Curr Clin Med. 2004;2:695-696.
44. Zhao FT, Xu SM, Zhang QH, et al. Citalopram versus venlafaxine for the improvement of post-stroke depression. Chin J Clin Rehabil. 2005;9:12-13.
45. Zhou MJ, Yao LQ. The efficacy and tolerability of venlafaxine and fluoxetine in the treatment of elderly patients with first-episode depression. Chin J Psychiatry. 2005;38:157-160.
46. Fang Y, Yuan C, Xu Y, et al. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a chinese population. J Clin Psychopharmacol. 2010;30:357-364.
47. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58:19-36. (Pubitemid 30173208)
48. Smith D, Dempster C, Glanville J, et al. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry. 2002;180:396-404. (Pubitemid 34499333)
49. van den Broek WW, Mulder PGH, van Os E, et al. Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis. J Psychopharmacol (Oxf ). 2009;23:708-713.
50. Ng CH, Norman TR, Khin ON, et al. A comparative study of sertraline dosages, plasma concentrations, efficacy and adverse reactions in Chinese versus Caucasian patients. Int Clin Psychopharmacol. 2006;21:87-92. (Pubitemid 43740315)
51. Zhang D, Yin P, Freemantle N, et al. An assessment of the quality of randomised controlled trials conducted in China. Trials. 2008;9:22.
52. Xu L, Li J, Zhang M, et al. Chinese authors do need CONSORT: reporting quality assessment for five leading Chinese medical journals. Contemp Clin Trials. 2008;29:727-731.
53. Berghmans T, Meert AP, Mascaux C, et al. Citation indexes do not reflect methodological quality in lung cancer randomised trials. Ann Oncol. 2003;14:715-721. (Pubitemid 36621771)
54. Medical Research Council. China-UK Research ethics (CURE) committee report. 2009. Available at: http://www.mrc.ac.uk/consumption/idcplg?IdcService= GET-FILE&dID=23592&dDocName=MRC006303&allowInterrupt=1. Accessed March 10, 2010.
55. Sim K, Lee NB, Chua HC, et al. Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. Br J Clin Pharmacol. 2007;63:431-437. (Pubitemid 46426630)